XML 250 R173.htm IDEA: XBRL DOCUMENT v3.26.1

List of subsidiaries (Details)	12 Months Ended
	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2025 HKD ($)	Dec. 31, 2025 GBP (£)	Dec. 31, 2025 TWD ($)
Disclosure of subsidiaries [line items]
Issued and fully paid share capital	$ 25,000	$ 19,000
Prenetics Limited
Disclosure of subsidiaries [line items]
Issued and fully paid share capital			$ 415,276,716
Directly	0.00%	0.00%
Indirectly	100.00%	100.00%
Europa Partners Holdings, LLC (note 33)
Disclosure of subsidiaries [line items]
Issued and fully paid share capital | £				£ 11.00
Directly	0.00%	0.00%
Indirectly	100.00%	100.00%
IM8 Group Holding Company
Disclosure of subsidiaries [line items]
Issued and fully paid share capital	$ 1
Directly	100.00%	100.00%
Indirectly	0.00%	0.00%
IM8 (US) LLC
Disclosure of subsidiaries [line items]
Directly	100.00%	100.00%
Indirectly	0.00%	0.00%
IM8 Limited
Disclosure of subsidiaries [line items]
Issued and fully paid share capital			1
Directly	100.00%	100.00%
Indirectly	0.00%	0.00%
ACT Genomics Holdings Company Limited
Disclosure of subsidiaries [line items]
Issued and fully paid share capital	$ 16,713
Directly	0.00%	73.27%
Indirectly	0.00%	0.00%
ACT Genomics Co., Ltd.
Disclosure of subsidiaries [line items]
Issued and fully paid share capital					$ 455,080,000
Directly	0.00%	0.00%
Indirectly	0.00%	73.21%
ACT Genomics (Hong Kong) Limited
Disclosure of subsidiaries [line items]
Issued and fully paid share capital			775,000
Directly	0.00%	0.00%
Indirectly	0.00%	73.27%
Sanomics Limited
Disclosure of subsidiaries [line items]
Issued and fully paid share capital			$ 500,000
Directly	0.00%	0.00%
Indirectly	0.00%	73.27%
MC Diagnostics Limited
Disclosure of subsidiaries [line items]
Issued and fully paid share capital | £				£ 1,164
Directly	0.00%	0.00%
Indirectly	0.00%	73.27%

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The nominal value of capital issued.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph B9
-Subparagraph f
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B
-URIDate 2025-03-27

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Note Expiry date 2027-01-01
-Name IAS
-Number 1
-IssueDate 2025-01-01
-Paragraph 78
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_IssuedCapital
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2025-01-01
-Paragraph 17
-Subparagraph b
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_iii&doctype=Standard
-URIDate 2025-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2025-01-01
-Paragraph 16
-Subparagraph b
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_iii&doctype=Standard
-URIDate 2025-03-27

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2025-01-01
-Paragraph 19B
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_c&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_ProportionOfOwnershipInterestInSubsidiary
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The proportion of the voting rights in a subsidiary held by the entity. [Refer: Total for all subsidiaries [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2025-01-01
-Paragraph 17
-Subparagraph b
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_iii&doctype=Standard
-URIDate 2025-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2025-01-01
-Paragraph 16
-Subparagraph b
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_iii&doctype=Standard
-URIDate 2025-03-27

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2025-01-01
-Paragraph 19B
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_c&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_ProportionOfVotingPowerHeldInSubsidiary
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:percentItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=pre_PreneticsLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=pre_EuropaPartnersHoldingsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=pre_IM8GroupHoldingCompayMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=pre_IM8USLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=pre_IM8LimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=pre_ActGenomicsHoldingsCompanyLimitedACTGenomicsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=pre_ActGenomicsCo.Ltd.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=pre_ActGenomicsHongKongLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=pre_SanomicsLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=pre_MCDiagnosticsLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: